Loading viewer...
investor_presentation
Format: PDF investor_presentation
Benchmark investor presentation dated April 2020.
April 29, 2020| 2
This press release contains forward -looking statements within the meaning of Section
27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of
1934. The words "expect," "estimate," "anticipate," "could" "predict" and similar
expressions, and the negatives thereof, often identify forward -looking statements,
which are not limited to historical facts. Forward -looking statements include, among
other things, the estimated financial impact of the COVID -19 pandemic, guidance for
second quarter 2020 results, the company’s anticipated plans and responses to the
COVID -19 pandemic, statements, express or implied, concerning future operating
results or margins, the ability to generate sales and income or cash flow, and expected
revenue mix; and Benchmark’s business and growth strategies. Although the company
believes these statements are based upon reasonable assumptions, they involve risks
and uncertainties relating to operations, markets and the business environment
generally. These statements also depend on the duration and severity of the COVID -
19 pandemic and related risks, including government and other third -party responses
to it and the consequences for the global economy, our business and the businesses of
our suppliers and customers. Events relating to or resulting from the COVID -19 crisis,
including the possibility of customer demand fluctuations, supply chain constraints, or
the ability to utilize our manufacturing facilities at sufficient levels to cover our fixed
operating costs, may have resulting impacts on the company’s business, financial
condition, results of operations, and the company’s ability (or inability) to execute on
its plans to respond to the COVID -19 pandemic. If one or more of these risks or
uncertainties materializes, or underlying assumptions prove incorrect, actual outcomes may vary materially from those indicated. Readers are advised to consult
further disclosures on these risks and uncertainties, particularly in Part 1, Item 1A,
"Risk Factors" of the company's Annual Report on Form 10 -K for the year
ended December 31, 2019 and in its subsequent filings with the Securities and
Exchange Commission. All forward -looking statements included in this document are
based upon information available to the company as of the date of this document, and
it assumes no obligation to update them.This document includes certain financial measures that exclude items and
therefore are not in accordance with U.S. generally accepted accounting
Preview truncated — download the full document for the complete content.
investor_presentation
22 Pages
Barclays
Intact Financial Investor Presentation — July 2020
investor_presentationinvestor_presentation
19 Pages
Intact Financial Corporation
investor_presentation
AIM ImmunoTech